Document is current
Any future updates will be listed below
-
Authors
Ahlstrom, Jenny
Costa, Luciano J. https://orcid.org/0000-0001-5362-2469
-
Funding
Funding for this research was provided by:
Johnson and Johnson
- License Information
-
More Information
Article History
Received: 11 August 2025
Accepted: 2 October 2025
First Online: 22 October 2025
Declarations
:
: Jenny Ahlstrom : Advisory boards: Bristol Myers Squibb, Johnson & Johnson, Pfizer, Regeneron, Sanofi, and Takeda Oncology; Luciano J. Costa : Honoraria: Amgen, Bristol Myers Squibb, AbbVie, Pfizer, Johnson & Johnson, Adaptive Biotechnologies, Sanofi, Genentech/Roche; Research Funding: Amgen, Bristol Myers Squibb, Johnson & Johnson, AbbVie, Caribou, Gracell, Genentech/Roche.
: This podcast article is based on data presented at the ASCO and EHA 2025 Congresses and it does not contain any new studies with human participants or animals performed by the authors.
